As of Nov 19, 2026, 0 of 1 active firms rate PETS a Buy (0 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
PETS EPS & revenue forecast
EPS · NEXT QUARTER
$0.06
Range $0.06 – $0.06 · 1 analysts · -132% YoY
Next period, 1 analysts expect PetMed Express Inc to earn $0.06 a share (range $0.06 – $0.06), versus $-0.19 a year earlier. , growing to $-0.35 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 1 analysts
Revenue is expected to reach $0 (range $0 – $0). Full-year consensus is $0, rising to $152.5M next year.
Top analysts covering PetMed Express Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on PETS.
#1
Erin Wright
Morgan Stanley · Rank #81
Sell
$1.40+57.3% to target
Overall win rate
55%
+ Follow
PETS stock forecast FAQ
What is PETS's average 12-month price target?+
The 1 active firms with a live target average $1.40 for PetMed Express Inc over the next 12 months, ranging from a $1.40 high to a $1.40 low, as of Nov 19, 2026.
Is PETS stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 1 active firms as of Nov 19, 2026, 0 rate it Buy or Strong Buy, 0 rate it Neutral, and 1 rate it Sell or Strong Sell.
How many active Wall Street firms cover PETS?+
1 active firms have a recognized rating on PetMed Express Inc as of Nov 19, 2026, and 1 active firms carry a live 12-month price target.
Who is the most accurate analyst covering PETS?+
Among analysts who currently cover PETS, Erin Wright of Morgan Stanley has the strongest overall Quantellect track record (Rank #81). Their current call is Sell with a $1.40 target.
What is PetMed Express Inc's projected EPS for next quarter?+
The consensus estimate is $0.06 per share (range $0.06 – $0.06) across 1 analysts. Full-year EPS is projected at —, rising to $-0.35 the following year.
How much revenue is PetMed Express Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $152.5M next year.
Have analysts been upgrading or downgrading PETS lately?+
As of Nov 19, 2026, 0 of 1 active firms rate PETS a Buy (0 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their PETS calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.